Stock CTNM CONTINEUM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Contineum Therapeutics, Inc.

Equities

CTNM

US21217B1008

Market Closed - Nasdaq
Other stock markets
 21:00:00 07/06/2024 BST 		5-day change 1st Jan Change
16.31 USD +1.18% Intraday chart for Contineum Therapeutics, Inc. +6.46% 0.00%
06-03 Contineum Therapeutics, Inc. Appoints John Healy as General Counsel & Corporate Secretary CI
05-20 Contineum Therapeutics, Inc. Appoints Troy Ignelzi as Independent Member of Its Board of Directors and as Chair of the Audit Committee CI

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CTNM Stock
  4. Revisions Contineum Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW